The Levonorgestrel-releasing intrauterine device: A wider role than contraception

被引:8
作者
Coleman, M [1 ]
McCowan, L [1 ]
Farquhar, C [1 ]
机构
[1] NATL WOMENS HOSP, DEPT OBSTET & GYNAECOL, AUCKLAND, NEW ZEALAND
关键词
D O I
10.1111/j.1479-828X.1997.tb02253.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The Levonorgestrel-releasing intrauterine device (LNG IUD) provides excellent contraception; it may reduce the rate of pelvic inflammatory disease (PID) and ectopic pregnancy compared to other 'modern' copper releasing IUDs; it can safely be used in the puerperium for breast-feeding mothers, and it significantly reduces menstrual blood loss and pain. While it was developed primarily as a contraceptive, its potential role in managing heavy and painful menstruation and the symptoms of the climacteric may eventually be just as important. Amongst developed countries New Zealand and Australia have some of the highest hysterectomy rates. By the age of 50 years 1 in 4 women in New Zealand and 1 in 5 women in Australia will have had a hysterectomy (A,B). In New Zealand 90% of these are performed for heavy menstrual breeding and fibroids (A). The LNG IUD has been shown to be effective treatment for both these conditions and its introduction to New Zealand and Australia would offer women an additional choice beyond surgery.
引用
收藏
页码:195 / 201
页数:7
相关论文
共 68 条
[31]   LEVONORGESTREL-RELEASING INTRAUTERINE-DEVICE [J].
LUUKKAINEN, T ;
LAHTEENMAKI, P ;
TOIVONEN, J .
ANNALS OF MEDICINE, 1990, 22 (02) :85-90
[32]  
LUUKKAINEN T, 1988, PROGR BIRTH CONTROL, P37
[33]   A COMPARISON OF FLURBIPROFEN, TRANEXAMIC ACID, AND A LEVONORGESTREL-RELEASING INTRAUTERINE CONTRACEPTIVE DEVICE IN THE TREATMENT OF IDIOPATHIC MENORRHAGIA [J].
MILSOM, I ;
ANDERSSON, K ;
ANDERSCH, B ;
RYBO, G .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (03) :879-883
[34]  
MISRA JS, 1995, ACTA CYTOL, V39, P45
[35]   ESTROGEN REPLACEMENT THERAPY .2. PROSPECTIVE-STUDY IN THE RELATIONSHIP TO CARCINOMA AND CARDIOVASCULAR AND METABOLIC PROBLEMS [J].
NACHTIGALL, LE ;
NACHTIGALL, RH ;
NACHTIGALL, RD ;
BECKMAN, EM .
OBSTETRICS AND GYNECOLOGY, 1979, 54 (01) :74-79
[36]   TISSUE CONCENTRATIONS OF LEVONORGESTREL IN WOMEN USING A LEVONORGESTREL-RELEASING IUD [J].
NILSSON, CG ;
HAUKKAMAA, M ;
VIEROLA, H ;
LUUKKAINEN, T .
CLINICAL ENDOCRINOLOGY, 1982, 17 (06) :529-536
[37]   CLINICAL-PERFORMANCE OF A NEW LEVONORGESTREL-RELEASING INTRAUTERINE-DEVICE - A RANDOMIZED COMPARISON WITH A NOVA-T-COPPER DEVICE [J].
NILSSON, CG ;
LUUKKAINEN, T ;
DIAZ, J ;
ALLONEN, H .
CONTRACEPTION, 1982, 25 (04) :345-356
[38]   FERTILITY AFTER DISCONTINUATION OF LEVONORGESTREL-RELEASING INTRAUTERINE-DEVICES [J].
NILSSON, CG .
CONTRACEPTION, 1982, 25 (03) :273-278
[39]   LEVONORGESTREL PLASMA-CONCENTRATIONS AND HORMONE PROFILES AFTER INSERTION AND AFTER 1 YEAR OF TREATMENT WITH A LEVONORGESTREL-IUD [J].
NILSSON, CG ;
LAHTEENMAKI, P ;
LUUKKAINEN, T .
CONTRACEPTION, 1980, 21 (03) :225-233
[40]   THE MODE OF ACTION OF IUDS [J].
ORTIZ, ME ;
CROXATTO, HB .
CONTRACEPTION, 1987, 36 (01) :37-53